Table 2. Association between 14-3-3σ expression and clinicopathological parameters of ESCC.

Variable		IHC expression
		Low expression (n = 124)	High expression (n = 44)	P
Age	<60	38(22.6%)	17(10.1%)	0.354
	≥60	86(51.2%)	27(16.1%)
Gender	Male	94(56.0%)	31(18.5%)	0.547
	Female	30(17.9%)	13(7.7%)
Histological grade*	Well differentiation	12(7.1%)	16(9.5%)	0.000
	Moderate differentiation	73(43.5%)	18(10.7%)
	Poor differentiation	39(23.2%)	10(6.0%)
T stage	T1+T2	22(13.8%)	10(6.3%)	0.368
	T3+T4	98(61.3%)	30(18.8%)
Lymph node metastasis	No	71(43.3%)	26(15.9%)	0.719
	Yes	51(31.1%)	16(9.8%)
TNM stage	I–II	73(46.8%)	24(15.4%)	1.0
	III–IV	45(28.9%)	14(9.0%)

*Well-differentiation vs. Moderate differentiation+Poor differentiation.